These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

284 related items for PubMed ID: 31158444

  • 21. Steroid profiling for the diagnosis of congenital adrenal hyperplasia by microbore ultra-performance liquid chromatography-tandem mass spectrometry.
    Feng D, Wang Z, Li H, Shi X, Zou L, Kong H, Xu Z, Yu C, Hu C, Xu G.
    Clin Chim Acta; 2023 Mar 15; 543():117304. PubMed ID: 36958425
    [Abstract] [Full Text] [Related]

  • 22. Twenty Years of Neonatal Screening for Congenital Adrenal Hyperplasia in North-Eastern Italy: Role of Liquid Chromatography-Tandem Mass Spectrometry as a Second-Tier Test.
    Cavarzere P, Camilot M, Palma L, Lauriola S, Gaudino R, Vincenzi M, Antoniazzi F, Teofoli F, Piacentini G.
    Horm Res Paediatr; 2022 Mar 15; 95(3):255-263. PubMed ID: 35350013
    [Abstract] [Full Text] [Related]

  • 23. Multiplexed steroid profiling of gluco- and mineralocorticoids pathways using a liquid chromatography tandem mass spectrometry method.
    Travers S, Martinerie L, Bouvattier C, Boileau P, Lombès M, Pussard E.
    J Steroid Biochem Mol Biol; 2017 Jan 15; 165(Pt B):202-211. PubMed ID: 27339652
    [Abstract] [Full Text] [Related]

  • 24. Monitoring steroid replacement therapy in children with congenital adrenal hyperplasia.
    Birkebaek NH, Hougaard DM, Cohen AS.
    J Pediatr Endocrinol Metab; 2017 Jan 01; 30(1):85-88. PubMed ID: 27977405
    [Abstract] [Full Text] [Related]

  • 25. Measuring steroids from dried blood spots using tandem mass spectrometry to diagnose congenital adrenal hyperplasia.
    Qasrawi DO, Boyd JM, Sadrzadeh SMH.
    Clin Chim Acta; 2021 Sep 01; 520():202-207. PubMed ID: 34097883
    [Abstract] [Full Text] [Related]

  • 26. An automated method on analysis of blood steroids using liquid chromatography tandem mass spectrometry: application to population screening for congenital adrenal hyperplasia in newborns.
    Dhillon K, Ho T, Rich P, Xu D, Lorey F, She J, Bhandal A.
    Clin Chim Acta; 2011 Nov 20; 412(23-24):2076-84. PubMed ID: 21803033
    [Abstract] [Full Text] [Related]

  • 27. Pilot proficiency testing study for second tier congenital adrenal hyperplasia newborn screening.
    De Jesús VR, Simms DA, Schiffer J, Kennedy M, Mei JV, Hannon WH.
    Clin Chim Acta; 2010 Nov 11; 411(21-22):1684-7. PubMed ID: 20619255
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Steroid profiling by tandem mass spectrometry improves the positive predictive value of newborn screening for congenital adrenal hyperplasia.
    Minutti CZ, Lacey JM, Magera MJ, Hahn SH, McCann M, Schulze A, Cheillan D, Dorche C, Chace DH, Lymp JF, Zimmerman D, Rinaldo P, Matern D.
    J Clin Endocrinol Metab; 2004 Aug 11; 89(8):3687-93. PubMed ID: 15292289
    [Abstract] [Full Text] [Related]

  • 30. Liquid chromatography quadrupole linear ion trap mass spectrometry for quantitative steroid hormone analysis in plasma, urine, saliva and hair.
    Gaudl A, Kratzsch J, Bae YJ, Kiess W, Thiery J, Ceglarek U.
    J Chromatogr A; 2016 Sep 16; 1464():64-71. PubMed ID: 27554022
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Serum steroid profiling for congenital adrenal hyperplasia using liquid chromatography-tandem mass spectrometry.
    Rossi C, Calton L, Hammond G, Brown HA, Wallace AM, Sacchetta P, Morris M.
    Clin Chim Acta; 2010 Feb 16; 411(3-4):222-8. PubMed ID: 19931522
    [Abstract] [Full Text] [Related]

  • 33. Analysis of 17 α-hydroxyprogesterone in bloodspots by liquid chromatography tandem mass spectrometry.
    Salter SJ, Cook P, Davies JH, Armston AE.
    Ann Clin Biochem; 2015 Jan 16; 52(Pt 1):126-34. PubMed ID: 24842631
    [Abstract] [Full Text] [Related]

  • 34. Sample-multiplexing by derivatization using multiple analogous reagents for enhancing throughput in LC/ESI-MS/MS assay of steroids: Plasma 17α-hydroxyprogesterone as an example.
    Kamemura M, Yokota M, Ogawa S, Sugiura T, Higashi T.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Jun 01; 1146():122117. PubMed ID: 32335501
    [Abstract] [Full Text] [Related]

  • 35. Functional glucocorticoid receptor gene variants do not underlie the high variability of 17-hydroxyprogesterone screening values in healthy newborns.
    Schreiner F, Tozakidou M, Maslak R, Holtkamp U, Peter M, Gohlke B, Woelfle J.
    Eur J Endocrinol; 2009 Apr 01; 160(4):667-73. PubMed ID: 19174530
    [Abstract] [Full Text] [Related]

  • 36. Use of steroid profiling by UPLC-MS/MS as a second tier test in newborn screening for congenital adrenal hyperplasia: the Utah experience.
    Schwarz E, Liu A, Randall H, Haslip C, Keune F, Murray M, Longo N, Pasquali M.
    Pediatr Res; 2009 Aug 01; 66(2):230-5. PubMed ID: 19390483
    [Abstract] [Full Text] [Related]

  • 37. Comparison of newborn screening protocols for congenital adrenal hyperplasia in preterm infants.
    Sarafoglou K, Gaviglio A, Hietala A, Frogner G, Banks K, McCann M, Thomas W.
    J Pediatr; 2014 May 01; 164(5):1136-40. PubMed ID: 24582106
    [Abstract] [Full Text] [Related]

  • 38. Rapid monitoring assay of congenital adrenal hyperplasia with microbore high-performance liquid chromatography/electrospray ionization tandem mass spectrometry from dried blood spots.
    Lai CC, Tsai CH, Tsai FJ, Lee CC, Lin WD.
    Rapid Commun Mass Spectrom; 2001 May 01; 15(22):2145-51. PubMed ID: 11746879
    [Abstract] [Full Text] [Related]

  • 39. Generation of monoclonal antibodies against 17α-hydroxyprogesterone for newborn screening of congenital adrenal hyperplasia.
    Morejón García G, García de la Rosa I, González Reyes EC, Rubio Torres A, Quintana Guerra JM, Hernández Marín M, Pérez Mora PL, Feal Carballo S, Lafita Delfino Y, Pupo Infante M, Castells Martínez EM, Rosabal Poloshkov A, Hernández Pérez L.
    Clin Chim Acta; 2018 Oct 01; 485():311-315. PubMed ID: 30006291
    [Abstract] [Full Text] [Related]

  • 40. Diagnosis of adrenal cortical dysfunction by liquid chromatography-tandem mass spectrometry.
    Kao PC, Machacek DA, Magera MJ, Lacey JM, Rinaldo P.
    Ann Clin Lab Sci; 2001 Apr 01; 31(2):199-204. PubMed ID: 11337910
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.